foto london banner.jpg

Something Powerful

Tell The Reader More

The headline and subheader tells us what you're offering, and the form header closes the deal. Over here you can explain why your offer is so great it's worth filling out a form for.

Remember:

  • Bullets are great
  • For spelling out benefits and
  • Turning visitors into leads.

Investment trends and outlook in 2017

Our Investor Perception Survey 2017 highlighted key trends around M&A, Inve...

Read More

Welcome to the Investor Portal

Our Investor Portal is a unique, powerful and searchable resource and libra...

Read More

Announcing the Launch of Biotech and Money's Healt...

Biotech and Money is proud to announce the launch of our inaugural Healthca...

Read More

40+ Must Know Life Science Investors

Who are some of the leading international investors most active this side o...

Read More

Issue 10, 2016 Drugs & Dealers Magazine Released

Biotech and Money are pleased to announce the release of the latest Drugs &...

Read More

Medicxi launches GSK and J&J backed 210 million Eu...

Francesco de Rubertis, Co-Founder and Partner of Medicxi Ventures, talks to...

Read More

Top Tips For Successful Private Fund Raise

Anker Lundemose, CEO of MISSION Therapeutics talks to Biotech and Money abo...

Read More

Investment Philosophies and Fundamental Trends

Biotech and Money had the opportunity to speak to Andy Smith CIO of Mann Bi...

Read More

Interview with Andy Richards, Serial Biotechnology...

We recently spoke to Andy Richards, Serial Biotechnology Entrepreneur and B...

Read More

Interview with Paul Claydon, Partner, Covington at...

We recently spoke to Paul Claydon, Partner, Covington at Biotech and Money ...

Read More

Exclusive Interview with Peter George, CEO, Clinig...

We recently spoke to Peter George, CEO, Clinigen at Biotech and Money Londo...

Read More

Francois Martelet, CEO and his aim for NetScientif...

3 months into his tenure as CEO of NetScientific, the vastly experienced in...

Read More

Add Your Response